Oral dysplasia is a potentially precancerous lesion diagnosed histologically. While the risk of progression is associated with histological grade, it is currently impossible to predict accurately which lesions will progress. Although most oral pathologists recognize and accept the criteria for grading epithelial dysplasia based on architectural and cytological changes, there can be considerable interexaminer and intraexaminer variation in the assessment of the presence or absence and the grade of oral epithelial dysplasia. This article reviews the alterations, criteria, different grading systems and the markers used for assessing the malignant transformation of epithelial dysplasia.
INTRODUCTION
The term 'Dysplasia' was introduced by Reagon 1958 in relation to the cells exfoliated from lesions of the uterine cervix. Dysplasia is an ominous premalignant change. In past, epithelial dysplasia, epithelial atypia and dyskeratosis were used synonymously. The first change suggesting malignant transformation is dysplasia. Dysplasia (dys = abnormal/bad; plasia = growth) is defined as 'A precancerous lesion of stratified squamous epithelium characterized by cellular atypia and loss of normal maturation and stratification short of carcinoma in situ'. Pindborg (1977) defined epithelial dysplasia as the term used for 'A lesion in which part of the thickness of the epithelium is replaced by the cells showing varying degree of cellular atypia'. 1 Lumermann et al (1995) defined epithelial dysplasia as 'A diagnostic term used to describe the histopathological changes seen in chronic progressive and premalignant disorders of oral mucosa'. 2 The presence of dysplastic areas in the epithelium of the upper aerodigestive tract is believed to be associated with a likely progression to cancer. Dysplastic features of a stratified squamous epithelium are characterized by cellular atypia and loss of normal maturation and stratification. 1 There is support for the view that the more severe the dysplasia the greater the likelihood is of progression to malignancy. 3 It has been demonstrated that the accumulation of genetic and epigenetic alteration takes place during malignant development and in the oral mucosa this is reflected by a series of well-defined clinical and histological changes depicting dysplasia. 4 The histological findings of dysplasia therefore indicate no more than a lesion has a statistically increased risk of malignant change, but cannot be used for confident prediction of malignant change in any individual case. Clearly, studies of potential biomarkers are needed in order to introduce more objectivity.
5

ALTERATIONS IN DYSPLASIA
Dysplasia refers to a series of subtle changes in cells signifying that anaplasia will develop soon. Dysplasia is theoretically reversible and therefore not yet malignant. Dysplasia is a premalignant change. It is a change at tissue level while atypia is a change at cellular level. Dysplasia is reversible and therefore a controlled cellular alteration. When the underlying inciting stimulus is removed, the dysplastic alterations revert to normal. The alteration in dysplasia includes genetic changes, epigenetic changes and surface alterations. The sum total of these physical and morphological alterations are of diagnostic and prognostic relevance and are designated as precancerous changes.
A genetic change involves complex process due to the interaction of the host (genetic factor) with carcinogens in the environment and includes activation of proto-oncogenes, inactivation of the tumor suppressor genes and inactivation of the genomic stability genes.
Epigenetic refers to heritable changes in the gene expression that occur without alteration in DNA sequence. CH Waddington in 1942 defined it as 'The branch of biology which studies the causal interactions between genes and their products which bring the phenotype into being'. 6 Chemical modifications to DNA and its associated proteins can alter gene expression without altering the DNA sequence whereas the genetic aberrations change the expression by altering the sequence of A-T and C-G. Epigenetic changes involve modifications in the activation of certain genes, but not the basic structure of DNA. Additionally, the chromatin proteins associated with DNA may be activated or silenced. This accounts for why the differentiated cells in a multicellular organism express only the genes that are necessary for their own activity. Epigenetic changes are preserved when cells divide. Most epigenetic changes only occur within the course of one individual organism's lifetime, but some epigenetic changes are inherited from one generation to the next. 6, 7 An Insight to Oral Epithelial Dysplasia
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Two primary and interconnected epigenetic mechanisms include DNA methylation and modification of histones. Also RNA is intimately involved in the formation of a repressive chromatin state.
The surface alteration includes cellular adaptations, reversible and irreversible changes. The reversible changes are reversible if causative factors are removed. If they persist, dysplastic cells escapes normal homeostatic control and assume the autonomy of tumor cells. The irreversible changes is characterized by accelerated cell division, which facilitates accumulation of genetic damage and further drives toward path of transformation and lead to cell death or neoplastic transformation.
CRITERIA FOR DYSPLASIA
When architectural disturbance is accompanied by cytological atypia (variations in the size and shape of the keratinocytes) the term dysplasia applies.
Criteria used for diagnosing oral epithelial dysplasia 3 are listed in Table 1 . These features could be broadly categorized as changes to the architecture (strata) of the epithelium and those that manifest as cellular atypia (Figs 1 to 9 Table 2 . They described a simple system for assessing epithelial dysplasia to produce a numerical score or epithelial atypia index. Katz et al (1985) 10 found the system to be of considerable value for purposes of standardization and eliminated observer bias by the use of standard photographs. They evaluated 13 histological features which were standardized by a set of photographs. Each feature was graded 'absent', 'slight' and 'marked' as follows:
Grading
Epithelial dysplasia index is the sum of 13 scores. Each feature carries a weighted score like basal cell hyperplasia = 4 and marked pleomorphism of cells and nuclei = 6. A grading of 'none' was scored 0 (zero). Grading of 'slight' or 'marked' was scored from 1 to 10.
• The grading finally was done as follows:
Total score (EDI) Grade
Mild dysplasia • 26-45 Moderate dysplasia • 46-75
Severe dysplasia
The drawback is that the system relies on the weighting of the individual criteria originally made by the authors and, therefore does not solve the problem of subjectivity. The system is rather laborious and has not gained wide use for routine diagnostic purposes. Warnakulasuriya (2001) 11 commented on this system and noted that even inflammatory or reactive lesions which are considered non-neoplastic may show some features of dysplasia.
Mehta et al (1971)
Mehta et al diagnosed epithelial dysplasia when two or more features of Smith-Pindborg criteria were present. 12 They diagnosed epithelial dysplasia using the following criteria:
Bancozy and Csiba (1976)
• Irregular epithelial stratification 
Grading
They graded epithelial dysplasia as:
• Mild: When two of the above listed histological changes were present.
• Moderate: When two to four changes were present.
• Severe: When five or more of the changes were present.
The drawback is that the grading was based on subjective interpretation of the features and did not take into account which factor was important in determining the malignant potential.
WHO System (1978)
The 12 histological characteristics that characterized the epithelial dysplasia are:
• Loss of polarity of basal cells • The presence of more than one layer of cells having basaloid appearance • An increased nuclear-cytoplasmic ratio • Drop-shaped rete pegs 13
Grading of Epithelial Dysplasia
• Mild dysplasia: Slight nuclear abnormalities, most marked in the basal third of the epithelial thickness and minimal in the upper layers, where the cell show maturation and stratification. A few, but no abnormal mitoses may be present, usually accompanied by keratosis and chronic inflammation.
• Moderate dysplasia: More marked nuclear abnormalities and nucleoli tend to be present, with changes most marked in the basal two-third of the epithelium, nuclear abnormalities may persist upto the surface, but cell maturation and stratification are evident in the upper layers. Mitoses are present in the parabasal and intermediate layers, but none is abnormal.
• Severe dysplasia: Marked nuclear abnormalities and loss of maturation involve more than two-third of the epithelium, with some stratification of the most superficial layers. Mitoses some of which are abnormal may be present in the upper layers.
Kramer (1980)
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This grading system suggests that an epithelium shows dysplasia if it has any two or more of the following features:
• Drop shaped rete pegs: Rete pegs that are wider in the deeper portions than they are more superficially. 
Grading
They graded dysplastic criteria for classification according to the degree of dysplasia and characteristics of carcinoma in situ as listed in Table 3 . 14 Shafer listed the criteria for epithelial dysplasia:
Shafer (1983)
• Increased and particularly abnormal mitosis • Individual cell keratinization • Epithelial pearls within spinous layer • Alteration in the nuclear cytoplasmic ratio 
Grading
Based on the number of individual histological features and extension of the cytological changes from the basal cell layer and upward epithelial dysplasia has been subdivided into:
• 
The dysplastic changes were graded as:
• Mild epithelial dysplasia: 'Minimal' dysplastic alterations confined to the lower third of the epithelium.
• Moderate epithelial dysplasia: Dysplastic changes seen in upto two-thirds of the thickness of the epithelium.
• Severe epithelial dysplasia: Dysplastic cells fill more than two-thirds but less than the entire thickness of the epithelium.
• Carcinoma in situ: The entire thickness of the epithelium contains less differentiated basaloid or squamous epithelial cell with enlarged, hyperchromatic nuclei and a variable number of typical and atypical mitotic figures with no invasion into the submucosa.
• Verrucous hyperplasia with dysplasia: The epithelium exhibits considerable thickening with surface papillations, hyperparakeratosis and parakeratin plugging and occasional dysplastic cells confined to the lower one-third of the epithelium.
16,19
Neville et al (1995) 20 Neville et al graded dysplasia as:
• Mild: Hyperchromatic and slightly pleomorphic nuclei are noted in the basal and suprabasal cell layers of stratified squamous epithelium.
• Moderate: Dysplastic changes extend from the basal layer to the midportion of the spinous layer and are characterized by nuclear hyperchromatism, pleomorphism and cellular crowding. Hyperkeratosis on the epithelial cell layer with prominent granular cell layer.
• Severe: Cellular crowding and disordered arrangement throughout most of the epithelial thickness, although slight maturation and flattening of the cells appears to be present at the epithelial surface. Epithelial cells are seen to mature very little as they progress toward the hyperparakeratotic surface.
• Carcinoma in situ: When the entire thickness of the epithelium is involved, the term carcinoma in situ is used. Dysplastic cells extend from the basal layer to the surface of the mucosa (top to bottom change) with no invasion into the underlying connective tissue.
Speight PM et al (1996) 21
They considered the thickness (height) to which the cellular and tissue changes may extend as important in grading dysplasia. • Drawback: Warnakulasuriya 2001 11 commented that there was wide variation in the thickness of the covering epithelium in the oral cavity, which leads to practical difficulties in using this grading system.
Kuffer and Lombardi (2002) 23
They felt the choice of clinical rather than histological criteria in the diagnosis and terminology of precancer is the cause of a disorderly mixture of dysplastic and nondysplastic lesions. Therefore, they proposed to dismember the classical 'oral precancerous lesions' to classify all cases which histologically do not show dysplasia into the category of 'risk lesions' (e.g. simple tobacco keratosis) and to place lesions with dysplasia (i.e. already engaged in the process of malignant transformation) into the category of 'precursors' of squamous cell carcinoma (e.g. tobacco keratosis with dysplasia). This 'precursor' term seems to be the most accurate to characterize the limited but already malignant intraepithelial alterations of dysplasia and carcinoma in situ, which herald the onset of an invasive squamous cell carcinoma. The drawback is that there was considerable difference in potential for transformation between lesions without dysplasia or with mild-moderate dysplasia and those with severe dysplasia, the application of the term 'risk lesion' to lesions without dysplasia which have a 'zero risk' of transformation (e.g. frictional keratosis) was inappropriate.
The use of the term 'precursor of oral squamous cell carcinoma' to dominate dysplastic lesions suggested that they were unequivocally associated with the future development of cancer. On the contrary, as demonstrated by Mincer et al, 24 20% of oral dysplasia regressed and 40% showed no modification in severity. According to Gupta et at 25 13% of cases regressed and 40% showed no modification in severity.
Richard 26 demonstrated that dysplasia and carcinoma in situ were different aspects of the same disease 'cervical intraepithelial neoplasm (CIN)' and treatment should be same for both. This concept of CIN has now replaced almost completely that of cervical dysplasia. It has been extended with some modification to oral mucosa as 'oral intraepithelial neoplasm (OIN)' and in general as 'squamous intraepithelial neoplasm (SIN)'. • Based on this Bethesda classification, the former system with three grades was replaced by a 2-grade system, which helped in better stratifying patients for clinical protocols. Accordingly they chose to report the diagnosis of oral dysplastic lesions as: -Low grade OIN-including OIN 1 (mild dysplasia) or as -High grade OIN-including OIN 2 (moderate dysplasia) and OIN 3 (severe dysplasia).
Ljubljana Grading System
This classification was developed to cater for the special clinical and histological problems of laryngeal abnormalities. 3 The classification was proposed for grading of epithelial hyperplastic lesions of the larynx, to hyperplastic epithelial lesions arising in the oral cavity.
Grading
• Simple hyperplasia: A benign hyperplastic process with retention of the normal pattern of the epithelium which is thickened because of an increase prickle cell layer. The cellular components of the basal and parabasal region remain unchanged. There is no cellular atypia. showing nuclear hyperchromatism and pleomorphism in entire thickness of the epithelium, with the suggestion of early superficial connective tissue invasion, but without convincing evidence. The advantage is that using this system, and a different method of statistical analysis, the authors proved that intra-and interobserver agreement in grading the dysplastic lesions were consistent and had almost perfect conformity.
WHO System (2005)
The criteria used for dysplasia are listed in Table 1 .
Grading
On the basis of architecture and cytology 28 • Hyperplasia: Describes increased cell numbers. This may be in the spinous layer leading to hyperplasia or acanthosis in the basal/parabasal cell layers (progenitor compartment), termed basal cell hyperplasia. Architecture shows regular stratification and there is no cellular atypia. Low-risk lesions (does not have the potential susceptibility for malignant transformation): It was associated with observation of less than four architectural changes or less than five cytological changes (WHO criteria 2005).
Biomarkers for Dysplasia
Currently, there is not a substantial body of strong evidence for the use of biomarkers in the progression of oral dysplasia. There is a suggestion from the longitudinal studies that the presence of LOH/A1 at specific loci (3p and 9p), survivin, MMP9 positivity and DNA content (nondiploid) are potential markers for increased risk of progression from oral dysplasia to cancer. 30 Other markers identified are p53, p73, MMP1, MMP2 and cathepsin L mRNA, but did not predict progression.
CONCLUSION
Grading of dysplasia continues to be a hotly debated subject. Dysplasia grading is also subjective with inter-and intraobserver variability. Moreover, due to the absence of a consensus, several systems are currently employed. There is no doubt that in future molecular biology discoveries and routine ways of assessing gross genomic aberrations will provide improved ways of assisting diagnosis and prediction of prognosis of oral dysplastic lesions and therefore, a better system for the prediction of cancer progression is needed.
Histopathological assessed severity of oral epithelial dysplasia remains the 'gold standard' for the prediction of malignant transformation of precancerous lesions.
